For research use only. Not for therapeutic Use.
RA-V (Cat No.:I042269) is a synthetic retinoid compound, a derivative of Vitamin A, that exhibits various bioactive properties. It is primarily studied for its potential in treating cancer, particularly through its ability to regulate gene expression and cell differentiation. RA-V has shown promise in preclinical studies for its anticancer activity, as it can induce apoptosis (programmed cell death) in tumor cells and inhibit their proliferation. Additionally, it has potential applications in skin diseases and other conditions related to cellular growth and differentiation. Ongoing research aims to explore its full therapeutic potential and safety.
Catalog Number | I042269 |
CAS Number | 64725-24-2 |
Synonyms | (1S,4R,7S,10S,13S,16S)-24-hydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexazatetracyclo[14.12.2.218,21.123,27]tritriaconta-18,20,23,25,27(31),32-hexaene-2,5,8,11,14,30-hexone |
Molecular Formula | C40H48N6O9 |
Purity | ≥95% |
IUPAC Name | 24-hydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexazatetracyclo[14.12.2.218,21.123,27]tritriaconta-18,20,23,25,27(31),32-hexaene-2,5,8,11,14,30-hexone |
InChI | InChI=1S/C40H48N6O9/c1-22-35(48)42-23(2)38(51)44(4)30(18-25-8-13-28(54-7)14-9-25)37(50)43-24(3)39(52)46(6)32-19-26-10-15-29(16-11-26)55-34-21-27(12-17-33(34)47)20-31(36(49)41-22)45(5)40(32)53/h8-17,21-24,30-32,47H,18-20H2,1-7H3,(H,41,49)(H,42,48)(H,43,50) |
InChIKey | VXVGFMUNENQGFW-UHFFFAOYSA-N |
SMILES | CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)O)C)C)CC5=CC=C(C=C5)OC)C)C |